Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dystrophin point mutation screening using a multiplexed protein truncation test.

N V Whittock1, R G Roberts, C G Mathew

  • 1Paediatric Research Unit, Guy's Hospital, London, UK.

Genetic Testing
|January 1, 1997
PubMed
Summary

This study introduces a new, cost-effective multiplexed protein truncation test (PTT) for high-throughput screening of dystrophin mutations. This efficient method accurately identifies point mutations in Duchenne muscular dystrophy patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management.

Cancer medicine·2025
Same author

Application of genetic testing criteria for hereditary breast cancer in South Africa.

Breast cancer research and treatment·2025
Same author

NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.

Mucosal immunology·2017
Same author

International cancer seminars: a focus on esophageal squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

What caused extinction of the Pleistocene megafauna of Sahul?

Proceedings. Biological sciences·2016
Same author

Defective macrophage handling of Escherichia coli in Crohn's disease.

Journal of gastroenterology and hepatology·2015

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder caused by mutations in the dystrophin gene.
  • Accurate and efficient screening for point mutations in the large dystrophin gene is crucial for diagnosis and research.
  • Existing methods for mutation screening can be time-consuming and costly.

Purpose of the Study:

  • To develop and validate a high-throughput, cost-effective multiplexed protein truncation test (PTT) for screening dystrophin point mutations.
  • To assess the efficiency of the multiplex PTT system in identifying mutations in DMD patients with previously uncharacterized mutations.

Main Methods:

  • Development of a robust and efficient multiplexed PTT using muscle biopsy or lymphocyte total RNA.

Related Experiment Videos

  • Utilized a long RT-PCR strategy to amplify the entire dystrophin open reading frame in five overlapping fragments (>3.7 kb).
  • In vitro transcription and translation of amplified fragments in a single multiplexed reaction with magnesium ions to minimize non-specific initiation.

    • Main Results:

    • Successfully screened 11 DMD patients (10 unrelated) with unknown mutations.
    • Identified a single truncating mutation in all analyzed patients, confirmed at the genomic level.
    • The multiplex PTT system demonstrated high efficiency for point mutation screening in the large dystrophin gene.

    Conclusions:

    • Multiplex PTT is the most efficient method for screening point mutations in the dystrophin gene.
    • This approach offers significant cost savings and improved efficiency compared to existing methods.
    • The multiplex PTT system has potential applications for screening mutations in other large disease genes with a high proportion of truncating mutations.